SCHEMBL3707772

SCHEMBL3707772

Fc1ccccc1-c1c(Cl)nc2nccn2c1Cl

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
GAA P10253 2/20 0.43
ALDH1A1 P00352 1/20 0.43
GLA P06280 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ADORA2A P29274 1/20 0.41
CCNE2 O96020 3/20 0.40
CCNE1 P24864 3/20 0.40
CDK2 P24941 3/20 0.40
GABRA1 P14867 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA3 P34903 1/20 0.35
MAP2K1 Q02750 1/20 0.34
NPC1 O15118 2/20 0.33
GRIA1 P42261 1/20 0.32
EGLN2 Q96KS0 1/20 0.32
TP53 P04637 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5247989 0.85 RAB9A (0.42) KDM4EGAAALDH1A1GLARAB9A
SCHEMBL5249517 0.82 SMN1; SMN2 (0.40) KDM4EGAAALDH1A1GLARAB9A
SCHEMBL361737 0.79 KDM4E (0.44) KDM4EGAAALDH1A1GLARAB9A
SCHEMBL5593404 0.78 EGLN2 (0.42) KDM4EGAAALDH1A1GLARAB9A
SCHEMBL363046 0.77 ALDH1A1 (0.42) KDM4EGAAALDH1A1GLARAB9A
SCHEMBL1478123 0.77 KDM4E (0.36) KDM4EGAAALDH1A1GLARAB9A
SCHEMBL8124935 0.74 EGLN2 (0.44) KDM4EGAAALDH1A1SMN1; SMN2EGLN2
SCHEMBL3704252 0.74 ADORA2A (0.41) KDM4EGAAADORA2ACCNE2CCNE1
SCHEMBL3702134 0.72 AKT1 (0.40) KDM4EGAAALDH1A1GLARAB9A
SCHEMBL5249870 0.71 PDE2A (0.39) KDM4EGAAALDH1A1GLARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396330-A1 FUSED PYRIMIDINES Bayer Pharma Aktiengesellschaft (DE) 2011-12-21 EP disclosed
WO-2010091808-A1 FUSED PYRIMIDINES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-08-19 WO disclosed